{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:37:03Z","timestamp":1788201423952,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["D202302048902"],"award-info":[{"award-number":["D202302048902"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"name":"College Student Innovation and Entrepreneurship Training Program of Hunan Province","award":["S202310555323"],"award-info":[{"award-number":["S202310555323"]}]},{"name":"Scientific Research Project of Hunan Provincial Department of Education","award":["23A0338"],"award-info":[{"award-number":["23A0338"]}]},{"name":"College Student Innovation and Entrepreneurship Training Program of Hunan Province","award":["S202210555279"],"award-info":[{"award-number":["S202210555279"]}]},{"name":"College Student Innovation and Entrepreneurship Training Program of Hunan Province","award":["S202310555104"],"award-info":[{"award-number":["S202310555104"]}]},{"name":"College Student Innovation and Entrepreneurship Training Program of Hunan Province","award":["S202310555321"],"award-info":[{"award-number":["S202310555321"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00109-024-02439-3","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T12:01:31Z","timestamp":1715342491000},"page":"831-840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mechanism of efferocytosis in atherosclerosis"],"prefix":"10.1007","volume":"102","author":[{"given":"Li-Xia","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Bao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3573-6638","authenticated-orcid":false,"given":"Shu-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"issue":"7","key":"2439_CR1","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/ATVBAHA.110.221127","volume":"31","author":"K Ley","year":"2011","unstructured":"Ley K, Miller YI, Hedrick CC (2011) Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 31(7):1506\u20131516","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2439_CR2","doi-asserted-by":"publisher","unstructured":"Golforoush P, Yellon DM, Davidson SM (2020) Mouse models of atherosclerosis and their suitability for the study of myocardial infarction. Basic Res Cardiol 115(6). https:\/\/doi.org\/10.1007\/s00395-020-00829-5","DOI":"10.1007\/s00395-020-00829-5"},{"issue":"7","key":"2439_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","volume":"21","author":"E Boada-Romero","year":"2020","unstructured":"Boada-Romero E et al (2020) The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol 21(7):398\u2013414","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2439_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-319-57613-8_7","volume":"1003","author":"MS Rahman","year":"2017","unstructured":"Rahman MS, Woollard K (2017) Atherosclerosis. Adv Exp Med Biol 1003:121\u2013144","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"2439_CR5","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/01.ATV.0000166517.18801.a7","volume":"25","author":"DM Schrijvers","year":"2005","unstructured":"Schrijvers DM et al (2005) Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol 25(6):1256\u20131261","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2439_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.tcb.2018.01.004","volume":"28","author":"KK Penberthy","year":"2018","unstructured":"Penberthy KK, Lysiak JJ, Ravichandran KS (2018) RethinkingPhagocytes: Clues from the Retina and Testes. Trends Cell Biol 28(4):317\u2013327","journal-title":"Trends Cell Biol"},{"issue":"7","key":"2439_CR7","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/molbev\/msx102","volume":"34","author":"AL Evans","year":"2017","unstructured":"Evans AL et al (2017) Antagonistic coevolution of MER tyrosine kinase expression and function. Mol Biol Evol 34(7):1613\u20131628","journal-title":"Mol Biol Evol"},{"issue":"14","key":"2439_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0960-9822(00)00598-4","volume":"10","author":"R Parnaik","year":"2000","unstructured":"Parnaik R, Raff MC, Scholes J (2000) Differences between the clearance of apoptotic cells by professional and non-professional phagocytes. Curr Biol 10(14):857\u2013860","journal-title":"Curr Biol"},{"issue":"9","key":"2439_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni.3253","volume":"16","author":"S Arandjelovic","year":"2015","unstructured":"Arandjelovic S, Ravichandran KS (2015) Phagocytosis of apoptotic cells in homeostasis. Nat Immunol 16(9):907\u2013917","journal-title":"Nat Immunol"},{"key":"2439_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41421-019-0108-8","volume":"5","author":"J Lu","year":"2019","unstructured":"Lu J et al (2019) Efficient engulfment of necroptotic and pyroptotic cells by nonprofessional and professional phagocytes. Cell Discov 5:39","journal-title":"Cell Discov"},{"issue":"5","key":"2439_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.immuni.2019.04.018","volume":"50","author":"S Morioka","year":"2019","unstructured":"Morioka S, Maueroder C, Ravichandran KS (2019) Living on the edge: efferocytosis at the interface of homeostasis and pathology. Immunity 50(5):1149\u20131162","journal-title":"Immunity"},{"issue":"6","key":"2439_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/cdd.2016.13","volume":"23","author":"CB Medina","year":"2016","unstructured":"Medina CB, Ravichandran KS (2016) Do not let death do us part: \u201cfind-me\u201d signals in communication between dying cells and the phagocytes. Cell Death Differ 23(6):979\u2013989","journal-title":"Cell Death Differ"},{"issue":"7801","key":"2439_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-020-2121-3","volume":"580","author":"CB Medina","year":"2020","unstructured":"Medina CB et al (2020) Metabolites released from apoptotic cells act as tissue messengers. Nature 580(7801):130\u2013135","journal-title":"Nature"},{"issue":"1","key":"2439_CR14","first-page":"20","volume":"119","author":"I Bournazou","year":"2009","unstructured":"Bournazou I et al (2009) Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest 119(1):20\u201332","journal-title":"J Clin Invest"},{"issue":"1","key":"2439_CR15","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.4110\/in.2018.18.e5","volume":"18","author":"M Lee","year":"2018","unstructured":"Lee M et al (2018) Tissue-specific role of CX(3)CR1 expressing immune cells and their relationships with human disease. Immune Netw 18(1):e5","journal-title":"Immune Netw"},{"issue":"13","key":"2439_CR16","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1182\/blood-2008-06-162404","volume":"112","author":"LA Truman","year":"2008","unstructured":"Truman LA et al (2008) CX3CL1\/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 112(13):5026\u20135036","journal-title":"Blood"},{"issue":"6","key":"2439_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(03)00422-7","volume":"113","author":"K Lauber","year":"2003","unstructured":"Lauber K et al (2003) Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113(6):717\u2013730","journal-title":"Cell"},{"issue":"8","key":"2439_CR18","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3109\/08916934.2012.719947","volume":"45","author":"C Peter","year":"2012","unstructured":"Peter C et al (2012) Release of lysophospholipid \u201cfind-me\u201d signals during apoptosis requires the ATP-binding cassette transporter A1. Autoimmunity 45(8):568\u2013573","journal-title":"Autoimmunity"},{"issue":"10","key":"2439_CR19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/aps.2013.92","volume":"34","author":"S Apostolakis","year":"2013","unstructured":"Apostolakis S, Spandidos D (2013) Chemokines and atherosclerosis: focus on the CX3CL1\/CX3CR1 pathway. Acta Pharmacol Sin 34(10):1251\u20131256","journal-title":"Acta Pharmacol Sin"},{"key":"2439_CR20","doi-asserted-by":"publisher","first-page":"e04069","DOI":"10.7554\/eLife.04069","volume":"4","author":"Y Gu","year":"2015","unstructured":"Gu Y et al (2015) Defective apical extrusion signaling contributes to aggressive tumor hallmarks. Elife 4:e04069","journal-title":"Elife"},{"issue":"30","key":"2439_CR21","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.2174\/092986707782793899","volume":"14","author":"T Matsumoto","year":"2007","unstructured":"Matsumoto T, Kobayashi T, Kamata K (2007) Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 14(30):3209\u20133220","journal-title":"Curr Med Chem"},{"issue":"3","key":"2439_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.molmed.2014.12.008","volume":"21","author":"D Ferrari","year":"2015","unstructured":"Ferrari D et al (2015) Purinergic signaling in atherosclerosis. Trends Mol Med 21(3):184\u2013192","journal-title":"Trends Mol Med"},{"issue":"1","key":"2439_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1139\/bcb-2020-0116","volume":"99","author":"X Zhao","year":"2021","unstructured":"Zhao X, Kruzel M, Aronowski J (2021) Lactoferrin and hematoma detoxification after intracerebral hemorrhage. Biochem Cell Biol 99(1):97\u2013101","journal-title":"Biochem Cell Biol"},{"issue":"3","key":"2439_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10534-022-00441-1","volume":"36","author":"C Chen","year":"2023","unstructured":"Chen C et al (2023) The role of lactoferrin in atherosclerosis. Biometals 36(3):509\u2013519","journal-title":"Biometals"},{"issue":"7","key":"2439_CR25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cbf.3433","volume":"37","author":"GHO da Rocha","year":"2019","unstructured":"da Rocha GHO et al (2019) Control of expression and activity of peroxisome proliferated-activated receptor gamma by Annexin A1 on microglia during efferocytosis. Cell Biochem Funct 37(7):560\u2013568","journal-title":"Cell Biochem Funct"},{"key":"2439_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cca.2022.05.009","volume":"531","author":"YZ Li","year":"2022","unstructured":"Li YZ et al (2022) Annexin A protein family in atherosclerosis. Clin Chim Acta 531:406\u2013417","journal-title":"Clin Chim Acta"},{"issue":"14","key":"2439_CR27","doi-asserted-by":"publisher","first-page":"12108","DOI":"10.1074\/jbc.M110.181800","volume":"286","author":"SC Frasch","year":"2011","unstructured":"Frasch SC et al (2011) Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity. J Biol Chem 286(14):12108\u201312122","journal-title":"J Biol Chem"},{"key":"2439_CR28","doi-asserted-by":"publisher","first-page":"659211","DOI":"10.3389\/fphys.2021.659211","volume":"12","author":"X Cui","year":"2021","unstructured":"Cui X et al (2021) The G2A receptor deficiency aggravates atherosclerosis in rats by regulating macrophages and lipid metabolism. Front Physiol 12:659211","journal-title":"Front Physiol"},{"issue":"2","key":"2439_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/resp.12949","volume":"22","author":"J Barnawi","year":"2017","unstructured":"Barnawi J et al (2017) Reduced DNA methylation of sphingosine-1 phosphate receptor 5 in alveolar macrophages in COPD: a potential link to failed efferocytosis. Respirology 22(2):315\u2013321","journal-title":"Respirology"},{"issue":"6","key":"2439_CR30","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/cdd.2016.11","volume":"23","author":"RB Birge","year":"2016","unstructured":"Birge RB et al (2016) Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ 23(6):962\u2013978","journal-title":"Cell Death Differ"},{"issue":"5","key":"2439_CR31","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1172\/JCI129277","volume":"129","author":"Y Kojima","year":"2019","unstructured":"Kojima Y et al (2019) Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest 129(5):2164","journal-title":"J Clin Invest"},{"key":"2439_CR32","doi-asserted-by":"publisher","first-page":"5245308","DOI":"10.1155\/2020\/5245308","volume":"2020","author":"C Khatana","year":"2020","unstructured":"Khatana C et al (2020) Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med Cell Longev 2020:5245308","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"2439_CR33","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1194\/jlr.M056689","volume":"56","author":"H Tao","year":"2015","unstructured":"Tao H et al (2015) Macrophage SR-BI mediates efferocytosis via Src\/PI3K\/Rac1 signaling and reduces atherosclerotic lesion necrosis. J Lipid Res 56(8):1449\u20131460","journal-title":"J Lipid Res"},{"issue":"7614","key":"2439_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima Y et al (2016) CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536(7614):86\u201390","journal-title":"Nature"},{"issue":"9","key":"2439_CR35","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1161\/CIRCRESAHA.120.315935","volume":"126","author":"G Caligiuri","year":"2020","unstructured":"Caligiuri G (2020) CD31 as a therapeutic target in atherosclerosis. Circ Res 126(9):1178\u20131189","journal-title":"Circ Res"},{"issue":"23","key":"2439_CR36","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.121.058615","volume":"146","author":"CP Manta","year":"2022","unstructured":"Manta CP et al (2022) Targeting of scavenger receptors stabilin-1 and stabilin-2 ameliorates atherosclerosis by a plasma proteome switch mediating monocyte\/macrophage suppression. Circulation 146(23):1783\u20131799","journal-title":"Circulation"},{"issue":"10","key":"2439_CR37","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1055\/s-0038-1669477","volume":"118","author":"W Lee","year":"2018","unstructured":"Lee W et al (2018) Macrophagic stabilin-1 restored disruption of vascular integrity caused by sepsis. Thromb Haemost 118(10):1776\u20131789","journal-title":"Thromb Haemost"},{"issue":"3","key":"2439_CR38","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1161\/ATVBAHA.115.306860","volume":"36","author":"AC Foks","year":"2016","unstructured":"Foks AC et al (2016) Blockade of Tim-1 and Tim-4 enhances atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 36(3):456\u2013465","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2439_CR39","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1161\/ATVBAHA.113.301879","volume":"33","author":"AC Foks","year":"2013","unstructured":"Foks AC et al (2013) T-cell immunoglobulin and mucin domain 3 acts as a negative regulator of atherosclerosis. Arterioscler Thromb Vasc Biol 33(11):2558\u20132565","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"17","key":"2439_CR40","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.117.031702","volume":"138","author":"PA Mueller","year":"2018","unstructured":"Mueller PA et al (2018) Deletion of macrophage low-density lipoprotein receptor-related protein 1 (LRP1) accelerates atherosclerosis regression and increases C-C chemokine receptor type 7 (CCR7) expression in plaque macrophages. Circulation 138(17):1850\u20131863","journal-title":"Circulation"},{"key":"2439_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/bs.ircmb.2020.09.001","volume":"357","author":"B Cai","year":"2020","unstructured":"Cai B, Kasikara C (2020) TAM receptors and their ligand-mediated activation: role in atherosclerosis. Int Rev Cell Mol Biol 357:21\u201333","journal-title":"Int Rev Cell Mol Biol"},{"issue":"10","key":"2439_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11883-020-00870-8","volume":"22","author":"K Tian","year":"2020","unstructured":"Tian K et al (2020) CD36 in atherosclerosis: pathophysiological mechanisms and therapeutic implications. Curr Atheroscler Rep 22(10):59","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"2439_CR43","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1160\/TH10-10-0630","volume":"105","author":"B Hurtado","year":"2011","unstructured":"Hurtado B et al (2011) Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques. Thromb Haemost 105(5):873\u2013882","journal-title":"Thromb Haemost"},{"issue":"16","key":"2439_CR44","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1161\/CIRCULATIONAHA.106.662080","volume":"115","author":"H Ait-Oufella","year":"2007","unstructured":"Ait-Oufella H et al (2007) Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 115(16):2168\u20132177","journal-title":"Circulation"},{"issue":"1","key":"2439_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2353\/ajpath.2007.060406","volume":"170","author":"VK Bhatia","year":"2007","unstructured":"Bhatia VK et al (2007) Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 170(1):416\u2013426","journal-title":"Am J Pathol"},{"issue":"2","key":"2439_CR46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.113.005991","volume":"130","author":"KS Heo","year":"2014","unstructured":"Heo KS et al (2014) ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis. Circulation 130(2):180\u2013191","journal-title":"Circulation"},{"issue":"8","key":"2439_CR47","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/cvr\/cvz100","volume":"115","author":"L McShane","year":"2019","unstructured":"McShane L et al (2019) TAM receptors in cardiovascular disease. Cardiovasc Res 115(8):1286\u20131295","journal-title":"Cardiovasc Res"},{"issue":"6885","key":"2439_CR48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/417182a","volume":"417","author":"R Hanayama","year":"2002","unstructured":"Hanayama R et al (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature 417(6885):182\u2013187","journal-title":"Nature"},{"issue":"7","key":"2439_CR49","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1074\/jbc.M704990200","volume":"283","author":"SN Maiti","year":"2008","unstructured":"Maiti SN et al (2008) Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. J Biol Chem 283(7):3761\u20136","journal-title":"J Biol Chem"},{"issue":"27","key":"2439_CR50","doi-asserted-by":"publisher","first-page":"9198","DOI":"10.1073\/pnas.0803677105","volume":"105","author":"M Nakaya","year":"2008","unstructured":"Nakaya M et al (2008) Spatiotemporal activation of Rac1 for engulfment of apoptotic cells. Proc Natl Acad Sci USA 105(27):9198\u20139203","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7769","key":"2439_CR51","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal AA et al (2019) CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature 572(7769):392\u2013396","journal-title":"Nature"},{"issue":"5473","key":"2439_CR52","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","volume":"288","author":"PA Oldenborg","year":"2000","unstructured":"Oldenborg PA et al (2000) Role of CD47 as a marker of self on red blood cells. Science 288(5473):2051\u20132054","journal-title":"Science"},{"issue":"23","key":"2439_CR53","doi-asserted-by":"publisher","first-page":"6932","DOI":"10.1093\/emboj\/17.23.6932","volume":"17","author":"H Miki","year":"1998","unstructured":"Miki H, Suetsugu S, Takenawa T (1998) WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J 17(23):6932\u20136941","journal-title":"EMBO J"},{"issue":"3","key":"2439_CR54","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr","year":"2020","unstructured":"Yurdagul A Jr et al (2020) Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab 31(3):518\u2013533","journal-title":"Cell Metab"},{"issue":"4","key":"2439_CR55","doi-asserted-by":"publisher","first-page":"e0174603","DOI":"10.1371\/journal.pone.0174603","volume":"12","author":"SY Kim","year":"2017","unstructured":"Kim SY et al (2017) Coordinated balance of Rac1 and RhoA plays key roles in determining phagocytic appetite. PLoS ONE 12(4):e0174603","journal-title":"PLoS ONE"},{"key":"2439_CR56","doi-asserted-by":"publisher","unstructured":"Yurdagul A Jr (2021) Metabolic consequences of efferocytosis and its impact on atherosclerosis. Immunometabolism 3(2). https:\/\/doi.org\/10.20900\/immunometab20210017","DOI":"10.20900\/immunometab20210017"},{"issue":"1","key":"2439_CR57","doi-asserted-by":"publisher","first-page":"e00017","DOI":"10.1097\/IN9.0000000000000017","volume":"5","author":"D Kumar","year":"2023","unstructured":"Kumar D, Pandit R, Yurdagul A Jr (2023) Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis. Immunometabolism (Cobham) 5(1):e00017","journal-title":"Immunometabolism (Cobham)"},{"issue":"23","key":"2439_CR58","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1073\/pnas.1524292113","volume":"113","author":"B Cai","year":"2016","unstructured":"Cai B et al (2016) MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc Natl Acad Sci USA 113(23):6526\u20136531","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2439_CR59","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1161\/ATVBAHA.120.315622","volume":"41","author":"A Yurdagul Jr","year":"2021","unstructured":"Yurdagul A Jr et al (2021) ODC (ornithine decarboxylase)-dependent putrescine synthesis maintains MerTK (MER tyrosine-protein kinase) expression to drive resolution. Arterioscler Thromb Vasc Biol 41(3):e144\u2013e159","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"38","key":"2439_CR60","doi-asserted-by":"publisher","first-page":"33335","DOI":"10.1074\/jbc.M111.263020","volume":"286","author":"E Thorp","year":"2011","unstructured":"Thorp E et al (2011) Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cdelta, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem 286(38):33335\u201333344","journal-title":"J Biol Chem"},{"issue":"2","key":"2439_CR61","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1172\/JCI90520","volume":"127","author":"B Cai","year":"2017","unstructured":"Cai B et al (2017) MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest 127(2):564\u2013568","journal-title":"J Clin Invest"},{"issue":"4","key":"2439_CR62","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/ATVBAHA.109.202051","volume":"30","author":"PG Yancey","year":"2010","unstructured":"Yancey PG et al (2010) Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler Thromb Vasc Biol 30(4):787\u2013795","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2439_CR63","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.111.032268","volume":"124","author":"PG Yancey","year":"2011","unstructured":"Yancey PG et al (2011) Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent. Circulation 124(4):454\u2013464","journal-title":"Circulation"},{"key":"2439_CR64","doi-asserted-by":"publisher","first-page":"682389","DOI":"10.3389\/fcvm.2021.682389","volume":"8","author":"J Chen","year":"2021","unstructured":"Chen J et al (2021) The dual role of low-density lipoprotein receptor-related protein 1 in atherosclerosis. Front Cardiovasc Med 8:682389","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2439_CR65","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/ATVBAHA.121.316854","volume":"42","author":"PA Mueller","year":"2022","unstructured":"Mueller PA et al (2022) Macrophage LRP1 (low-density lipoprotein receptor-related protein 1) is required for the effect of CD47 blockade on efferocytosis and atherogenesis-brief report. Arterioscler Thromb Vasc Biol 42(1):e1\u2013e9","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7757","key":"2439_CR66","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1140-4","volume":"569","author":"L Huang","year":"2019","unstructured":"Huang L et al (2019) SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis. Nature 569(7757):565\u2013569","journal-title":"Nature"},{"key":"2439_CR67","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2018.05.009","volume":"276","author":"P Yu","year":"2018","unstructured":"Yu P et al (2018) PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice. Atherosclerosis 276:171\u2013181","journal-title":"Atherosclerosis"},{"issue":"1","key":"2439_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1161\/CIRCRESAHA.112.280081","volume":"112","author":"S Saddar","year":"2013","unstructured":"Saddar S et al (2013) Scavenger receptor class B type I is a plasma membrane cholesterol sensor. Circ Res 112(1):140\u2013151","journal-title":"Circ Res"},{"key":"2439_CR69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pharmthera.2018.02.003","volume":"188","author":"A Tajbakhsh","year":"2018","unstructured":"Tajbakhsh A et al (2018) Efferocytosis in atherosclerotic lesions: malfunctioning regulatory pathways and control mechanisms. Pharmacol Ther 188:12\u201325","journal-title":"Pharmacol Ther"},{"key":"2439_CR70","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-cellbio-111315-125315","volume":"33","author":"PM Henson","year":"2017","unstructured":"Henson PM (2017) Cell removal: efferocytosis. Annu Rev Cell Dev Biol 33:127\u2013144","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2439_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","volume":"32","author":"AN Barclay","year":"2014","unstructured":"Barclay AN, Van den Berg TK (2014) The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target. Annu Rev Immunol 32:25\u201350","journal-title":"Annu Rev Immunol"},{"key":"2439_CR72","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.vph.2018.10.001","volume":"114","author":"S Kumar","year":"2019","unstructured":"Kumar S et al (2019) Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis. Vascul Pharmacol 114:76\u201392","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"2439_CR73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCRESAHA.117.311802","volume":"122","author":"T Sallam","year":"2018","unstructured":"Sallam T, Sandhu J, Tontonoz P (2018) Long noncoding RNA discovery in cardiovascular disease: decoding form to function. Circ Res 122(1):155\u2013166","journal-title":"Circ Res"},{"issue":"2","key":"2439_CR74","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41419-019-1409-4","volume":"10","author":"ZM Ye","year":"2019","unstructured":"Ye ZM et al (2019) LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death Dis 10(2):138","journal-title":"Cell Death Dis"},{"key":"2439_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-017-8765-9","volume-title":"MFG-E8 and inflammation","author":"P Wang","year":"2014","unstructured":"Wang P (2014) MFG-E8 and inflammation. Springer, Netherlands"},{"issue":"4","key":"2439_CR76","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.4049\/jimmunol.0803444","volume":"182","author":"B Toth","year":"2009","unstructured":"Toth B et al (2009) Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol 182(4):2084\u20132092","journal-title":"J Immunol"},{"issue":"4","key":"2439_CR77","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","volume":"22","author":"P Roy","year":"2022","unstructured":"Roy P, Orecchioni M, Ley K (2022) How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat Rev Immunol 22(4):251\u2013265","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2439_CR78","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1073\/pnas.96.11.6353","volume":"96","author":"MK Chang","year":"1999","unstructured":"Chang MK et al (1999) Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA 96(11):6353\u20136358","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"2439_CR79","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.112.100339","volume":"126","author":"A Polykratis","year":"2012","unstructured":"Polykratis A et al (2012) Conditional targeting of tumor necrosis factor receptor-associated factor 6 reveals opposing functions of Toll-like receptor signaling in endothelial and myeloid cells in a mouse model of atherosclerosis. Circulation 126(14):1739\u20131751","journal-title":"Circulation"},{"key":"2439_CR80","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","volume":"27","author":"FO Martinez","year":"2009","unstructured":"Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451\u2013483","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"2439_CR81","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9):6425\u20136440","journal-title":"J Cell Physiol"},{"issue":"10","key":"2439_CR82","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"KJ Moore","year":"2013","unstructured":"Moore KJ, Sheedy FJ, Fisher EA (2013) Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13(10):709\u2013721","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2439_CR83","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1286-4579(00)01359-9","volume":"3","author":"X Ma","year":"2001","unstructured":"Ma X (2001) TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect 3(2):121\u2013129","journal-title":"Microbes Infect"},{"issue":"Pt A","key":"2439_CR84","doi-asserted-by":"publisher","first-page":"109260","DOI":"10.1016\/j.intimp.2022.109260","volume":"113","author":"Y Xie","year":"2022","unstructured":"Xie Y et al (2022) Novel insight on the role of macrophages in atherosclerosis: focus on polarization, apoptosis and efferocytosis. Int Immunopharmacol 113(Pt A):109260","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"2439_CR85","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/eji.201948351","volume":"50","author":"X Ji","year":"2020","unstructured":"Ji X et al (2020) Sphingosine 1-phosphate\/microRNA-1249-5p\/MCP-1 axis is involved in macrophage-associated inflammation in fatty liver injury in mice. Eur J Immunol 50(11):1746\u20131756","journal-title":"Eur J Immunol"},{"issue":"11","key":"2439_CR86","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1172\/JCI94735","volume":"127","author":"AC Doran","year":"2017","unstructured":"Doran AC et al (2017) CAMKIIgamma suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis. J Clin Invest 127(11):4075\u20134089","journal-title":"J Clin Invest"},{"issue":"4","key":"2439_CR87","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1161\/CIRCRESAHA.118.313028","volume":"124","author":"ML Brophy","year":"2019","unstructured":"Brophy ML et al (2019) Myeloid-specific deletion of epsins 1 and 2 reduces atherosclerosis by preventing LRP-1 downregulation. Circ Res 124(4):e6\u2013e19","journal-title":"Circ Res"},{"issue":"5","key":"2439_CR88","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1189\/jlb.0307192","volume":"82","author":"D Cui","year":"2007","unstructured":"Cui D et al (2007) Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J Leukoc Biol 82(5):1040\u20131050","journal-title":"J Leukoc Biol"},{"issue":"10","key":"2439_CR89","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1161\/CIRCRESAHA.117.312333","volume":"122","author":"M Viaud","year":"2018","unstructured":"Viaud M et al (2018) Lysosomal cholesterol hydrolysis couples efferocytosis to anti-inflammatory oxysterol production. Circ Res 122(10):1369\u20131384","journal-title":"Circ Res"},{"key":"2439_CR90","doi-asserted-by":"publisher","unstructured":"Cai B et al (2018) MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. Sci Signal 11(549). https:\/\/doi.org\/10.20900\/immunometab20210017","DOI":"10.20900\/immunometab20210017"},{"issue":"7733","key":"2439_CR91","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41586-018-0735-5","volume":"563","author":"S Morioka","year":"2018","unstructured":"Morioka S et al (2018) Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release. Nature 563(7733):714\u2013718","journal-title":"Nature"},{"issue":"4","key":"2439_CR92","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/ATVBAHA.114.304723","volume":"35","author":"Y Wei","year":"2015","unstructured":"Wei Y et al (2015) Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis. Arterioscler Thromb Vasc Biol 35(4):796\u2013803","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2439_CR93","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1038\/s41467-020-19664-2","volume":"11","author":"V Simion","year":"2020","unstructured":"Simion V et al (2020) A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus. Nat Commun 11(1):6135","journal-title":"Nat Commun"},{"key":"2439_CR94","doi-asserted-by":"publisher","first-page":"731769","DOI":"10.3389\/fphar.2021.731769","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) Guanxinkang decoction attenuates the inflammation in atherosclerosis by regulating efferocytosis and MAPKs signaling pathway in LDLR(-\/-) mice and RAW264.7 cells. Front Pharmacol 12:731769","journal-title":"Front Pharmacol"},{"issue":"7","key":"2439_CR95","doi-asserted-by":"publisher","first-page":"e0180213","DOI":"10.1371\/journal.pone.0180213","volume":"12","author":"X Du","year":"2017","unstructured":"Du X et al (2017) Isoflurane promotes phagocytosis of apoptotic neutrophils through AMPK-mediated ADAM17\/Mer signaling. PLoS ONE 12(7):e0180213","journal-title":"PLoS ONE"},{"issue":"11","key":"2439_CR96","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1161\/CIRCRESAHA.113.301656","volume":"113","author":"G Bories","year":"2013","unstructured":"Bories G et al (2013) Liver X receptor activation stimulates iron export in human alternative macrophages. Circ Res 113(11):1196\u20131205","journal-title":"Circ Res"},{"issue":"1","key":"2439_CR97","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1038\/s41598-019-46942-x","volume":"9","author":"D Engelbertsen","year":"2019","unstructured":"Engelbertsen D et al (2019) Increased lymphocyte activation and atherosclerosis in CD47-deficient mice. Sci Rep 9(1):10608","journal-title":"Sci Rep"},{"issue":"8","key":"2439_CR98","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","volume":"19","author":"SE Engelen","year":"2022","unstructured":"Engelen SE et al (2022) Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat Rev Cardiol 19(8):522\u2013542","journal-title":"Nat Rev Cardiol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-024-02439-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T06:02:26Z","timestamp":1719554546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-024-02439-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2439"],"URL":"https:\/\/doi.org\/10.1007\/s00109-024-02439-3","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"4 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}